- Home
- THRD vs MBI Comparison
THRD vs MBI Comparison
Compare THRD & MBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- MBI
- Stock Information
- Founded
- THRD 2019
- MBI 1973
- Country
- THRD United States
- MBI United States
- Employees
- THRD N/A
- MBI N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- MBI Property-Casualty Insurers
- Sector
- THRD Health Care
- MBI Finance
- Exchange
- THRD Nasdaq
- MBI Nasdaq
- Market Cap
- THRD 238.7M
- MBI 229.2M
- IPO Year
- THRD 2022
- MBI 1987
- Fundamental
- Price
- THRD $5.42
- MBI $4.27
- Analyst Decision
- THRD Hold
- MBI Buy
- Analyst Count
- THRD 3
- MBI 2
- Target Price
- THRD $5.00
- MBI $6.25
- AVG Volume (30 Days)
- THRD 251.2K
- MBI 179.7K
- Earning Date
- THRD 08-07-2025
- MBI 08-05-2025
- Dividend Yield
- THRD N/A
- MBI N/A
- EPS Growth
- THRD N/A
- MBI N/A
- EPS
- THRD N/A
- MBI N/A
- Revenue
- THRD N/A
- MBI $37,000,000.00
- Revenue This Year
- THRD N/A
- MBI N/A
- Revenue Next Year
- THRD N/A
- MBI N/A
- P/E Ratio
- THRD N/A
- MBI N/A
- Revenue Growth
- THRD N/A
- MBI 285.71
- 52 Week Low
- THRD $3.18
- MBI $3.22
- 52 Week High
- THRD $16.02
- MBI $7.46
- Technical
- Relative Strength Index (RSI)
- THRD 68.70
- MBI 44.55
- Support Level
- THRD $5.41
- MBI $4.11
- Resistance Level
- THRD $5.52
- MBI $4.45
- Average True Range (ATR)
- THRD 0.05
- MBI 0.15
- MACD
- THRD -0.01
- MBI 0.00
- Stochastic Oscillator
- THRD 64.29
- MBI 37.21
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.